Results 151 to 160 of about 12,704,328 (364)

Epistemic injustice in academic global health.

open access: yesLancet Global Health, 2021
Himani Bhakuni, S. Abimbola
semanticscholar   +1 more source

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira   +14 more
wiley   +1 more source

The impact of chronic kidney disease on global health

open access: yesNature Reviews Nephrology, 2020
Ellen F. Carney
semanticscholar   +1 more source

The influence of ROS1 fusion partners and resistance mechanisms in ROS1‐TKI‐treated non‐small cell lung cancer patients

open access: yesMolecular Oncology, EarlyView.
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga   +8 more
wiley   +1 more source

Surprise us, Mr Trump

open access: yesThe Lancet Global Health, 2017
The Lancet Global Health
doaj   +1 more source

No time for complacency on the road to gender equality

open access: yesThe Lancet Global Health, 2020
The Lancet Global Health
doaj   +1 more source

Home - About - Disclaimer - Privacy